FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved the original application for generic mycophenolate mofetil (Sandoz) for prevention of organ transplant rejection in kidney, heart, and liver transp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)